To access the full text documents, please follow this link:

Hipertensión arterial y enfermedad de Alzheimer
Coll de Tuero, Gabriel
Hypertension (HT) is the most prevalent cardiovascular risk factor associated with dementia and Alzheimer disease (AD). The evidence about the association within hight blood pressure (BP) level in the middle age and dementia and Alzheimer’s disease incidence in the advanced age has increased. Longitudinal studies show that in the previous years of onset AD, BP is similar or lower in the patients who develop AD with regard to those who not develop. When patients has developed AD the case is the same that the previous one. Most studies show that BP reduction is beneficious to prevent cognitive impairment, dementia and AD. Is spite of some discordant studies, health authorities recommend to treat isolated systolic HT with an ‘A’ evidence degree, level 1, to prevent AD. Animal experimentation prove different ways to act of antihypertensive drugs in the AD prevention and has established the pathophysiological bases in this relation, until now only showed through various clinical studies
Alzheimer, Malaltia d' -- Tractament
Alzheimer's disease -- Treatment
Tots els drets reservats
Editorial Glosa

Show full item record

Related documents

Other documents of the same author

Rodríguez Poncelas, Antonio; Coll de Tuero, Gabriel; Sáez Zafra, Marc; Garrido Martín, José M.; Millaruelo-Trillo, José M.; Barrot de-la-Puente, Joan; Franch Nadal, Josep; RedGDPS Study Group
Barceló Rado, María Antonia; Coll-Negre, Montserrat; Coll de Tuero, Gabriel; Sáez Zafra, Marc
Carrión Ribas, Carme; Toran Monserrat, Pere; Zamora Cervantes, Alberto; Balló Peña, Elisabet; Quesada Sabaté, Miquel; Grau Martín, Armand; Castro Guardiola, Antoni; Cerezo Goyeneche, Carlos; Torrent Goñi, Silvia; Vargas Vila, Susanna; Galí Pla, Bibiana; Vilert Garrofa, Esther; Subirats Bayego, Enric; Coll de Tuero, Gabriel; Muñoz Ortiz, Laura; Cordón i Granados, Ferran